Transcatether Aortic Valve Implantation to Treat Degenerated Surgical Bioprosthesis: Focus on the Specific Procedural Challenges

Cristina Aurigemma; Francesco Burzotta; Rocco Vergallo; Piero Farina; Enrico Romagnoli; Stefano Cangemi; Francesco Bianchini; Marialisa Nesta; Piergiorgio Bruno; Domenico D'Amario; Antonio Maria Leone; Carlo Trani

doi:10.3389/fcvm.2022.895477

Transcatether Aortic Valve Implantation to Treat Degenerated Surgical Bioprosthesis: Focus on the Specific Procedural Challenges

Cristina Aurigemma, Francesco Burzotta, Rocco Vergallo, Piero Farina, Enrico Romagnoli, Stefano Cangemi, Francesco Bianchini, Marialisa Nesta, Piergiorgio Bruno, Domenico D'Amario, Antonio Maria Leone, Carlo Trani

Risultato della ricerca: Contributo su rivista › Articolo di review › peer review

Abstract

Actually transcatheter aortic valve implantation within failed surgically bioprosthetic valves (VIV-TAVI) is an established procedure in patients at high risk for repeat surgical aortic valve intervention. Although less invasive than surgical reintervention, VIV-TAVI procedure offers potential challenges, such as higher rates of prosthesis-patient mismatch and coronary obstruction. Thus, optimal procedural planning plays an important role to minimize the risk of procedure complications. In this review, we describe the key points of a VIV-TAVI procedure to optimize outcomes and reduce the risk of procedure complications.

Lingua originale	Inglese
Numero di articolo	895477
Rivista	Frontiers in Cardiovascular Medicine
Volume	9
DOI	https://doi.org/10.3389/fcvm.2022.895477
Stato di pubblicazione	Pubblicato - 31 mag 2022
Pubblicato esternamente	Sì

Accesso al documento

10.3389/fcvm.2022.895477

Altri file e collegamenti

Link to publication in Scopus

Cita questo

Aurigemma, C., Burzotta, F., Vergallo, R., Farina, P., Romagnoli, E., Cangemi, S., Bianchini, F., Nesta, M., Bruno, P., D'Amario, D., Leone, A. M., & Trani, C. (2022). Transcatether Aortic Valve Implantation to Treat Degenerated Surgical Bioprosthesis: Focus on the Specific Procedural Challenges. Frontiers in Cardiovascular Medicine, 9, Articolo 895477. https://doi.org/10.3389/fcvm.2022.895477

@article{efca315c54ae40a6951c9cea638dd24d,

title = "Transcatether Aortic Valve Implantation to Treat Degenerated Surgical Bioprosthesis: Focus on the Specific Procedural Challenges",

abstract = "Actually transcatheter aortic valve implantation within failed surgically bioprosthetic valves (VIV-TAVI) is an established procedure in patients at high risk for repeat surgical aortic valve intervention. Although less invasive than surgical reintervention, VIV-TAVI procedure offers potential challenges, such as higher rates of prosthesis-patient mismatch and coronary obstruction. Thus, optimal procedural planning plays an important role to minimize the risk of procedure complications. In this review, we describe the key points of a VIV-TAVI procedure to optimize outcomes and reduce the risk of procedure complications.",

keywords = "cerebral embolization, coronary occlusion, degenerated surgical bioprosthesis, post procedural gradient, stentless aortic bioprosthesis, sutureless aortic bioprosthesis, valve in valve",

author = "Cristina Aurigemma and Francesco Burzotta and Rocco Vergallo and Piero Farina and Enrico Romagnoli and Stefano Cangemi and Francesco Bianchini and Marialisa Nesta and Piergiorgio Bruno and Domenico D'Amario and Leone, \{Antonio Maria\} and Carlo Trani",

note = "Publisher Copyright: Copyright {\textcopyright} 2022 Aurigemma, Burzotta, Vergallo, Farina, Romagnoli, Cangemi, Bianchini, Nesta, Bruno, D'Amario, Leone and Trani.",

year = "2022",

month = may,

day = "31",

doi = "10.3389/fcvm.2022.895477",

language = "English",

volume = "9",

journal = "Frontiers in Cardiovascular Medicine",

issn = "2297-055X",

publisher = "Frontiers Media S.A.",

}

Aurigemma, C, Burzotta, F, Vergallo, R, Farina, P, Romagnoli, E, Cangemi, S, Bianchini, F, Nesta, M, Bruno, P, D'Amario, D, Leone, AM & Trani, C 2022, 'Transcatether Aortic Valve Implantation to Treat Degenerated Surgical Bioprosthesis: Focus on the Specific Procedural Challenges', Frontiers in Cardiovascular Medicine, vol. 9, 895477. https://doi.org/10.3389/fcvm.2022.895477

TY - JOUR

T1 - Transcatether Aortic Valve Implantation to Treat Degenerated Surgical Bioprosthesis

T2 - Focus on the Specific Procedural Challenges

AU - Aurigemma, Cristina

AU - Burzotta, Francesco

AU - Vergallo, Rocco

AU - Farina, Piero

AU - Romagnoli, Enrico

AU - Cangemi, Stefano

AU - Bianchini, Francesco

AU - Nesta, Marialisa

AU - Bruno, Piergiorgio

AU - D'Amario, Domenico

AU - Leone, Antonio Maria

AU - Trani, Carlo

PY - 2022/5/31

Y1 - 2022/5/31

N2 - Actually transcatheter aortic valve implantation within failed surgically bioprosthetic valves (VIV-TAVI) is an established procedure in patients at high risk for repeat surgical aortic valve intervention. Although less invasive than surgical reintervention, VIV-TAVI procedure offers potential challenges, such as higher rates of prosthesis-patient mismatch and coronary obstruction. Thus, optimal procedural planning plays an important role to minimize the risk of procedure complications. In this review, we describe the key points of a VIV-TAVI procedure to optimize outcomes and reduce the risk of procedure complications.

AB - Actually transcatheter aortic valve implantation within failed surgically bioprosthetic valves (VIV-TAVI) is an established procedure in patients at high risk for repeat surgical aortic valve intervention. Although less invasive than surgical reintervention, VIV-TAVI procedure offers potential challenges, such as higher rates of prosthesis-patient mismatch and coronary obstruction. Thus, optimal procedural planning plays an important role to minimize the risk of procedure complications. In this review, we describe the key points of a VIV-TAVI procedure to optimize outcomes and reduce the risk of procedure complications.

KW - cerebral embolization

KW - coronary occlusion

KW - degenerated surgical bioprosthesis

KW - post procedural gradient

KW - stentless aortic bioprosthesis

KW - sutureless aortic bioprosthesis

KW - valve in valve

UR - https://www.scopus.com/pages/publications/85136669028

U2 - 10.3389/fcvm.2022.895477

DO - 10.3389/fcvm.2022.895477

M3 - Review article

SN - 2297-055X

VL - 9

JO - Frontiers in Cardiovascular Medicine

JF - Frontiers in Cardiovascular Medicine

M1 - 895477

ER -

Transcatether Aortic Valve Implantation to Treat Degenerated Surgical Bioprosthesis: Focus on the Specific Procedural Challenges

Abstract

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo